FDA Inspection
Northern Biomedical Research, Inc.Northern Biomedical Research, Inc. – FDA Inspection, Jul 31, 2026
Record Details
This FDA Inspection record concerns Northern Biomedical Research, Inc., with an inspection on July 31, 2026, issued by the Detroit District Office, covering biologics.
View Company Profile
ID · e6cb61da-4192-42a3-b970-05be101c71f5
Inspection Facts
- Inspection number
- 1324348
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
16- 21 CFR 58.130(a)Conduct: in accordance with protocol
- 21 CFR 58.130(c)Conduct: identification of test specimens
- 21 CFR 58.185(a)Final report: non-existent
- 21 CFR 58.185(a)(14)Final report: statement by QAU
- 21 CFR 58.185(a)(9)Final report: circumstances affecting data qual., integrity
- 21 CFR 58.190(b)Archives: reference other storage locations
- 21 CFR 58.190(c)Archives: individual responsible
- 21 CFR 58.29(a)Personnel: education, training, experience
- 21 CFR 58.35(b)(5)QAU: authorize deviations from protocols or SOPs
- 21 CFR 58.35(b)(6)QAU: review final study report
Showing 10 of 16 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northern Biomedical Research, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 29, 2024 | VAI | Detroit District Office | Human Cellular, Tissue, and Gene Therapies |
Other documents for Northern Biomedical Research, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.